Skip to main content
HPB : The Official Journal of the International Hepato Pancreato Biliary Association logoLink to HPB : The Official Journal of the International Hepato Pancreato Biliary Association
. 2002;4(1):35–38. doi: 10.1080/136518202753598717

Management of hepatobiliary and pancreatic disorders at the Academic Medical Center Amsterdam, Netherlands

DJ Gouma , H Obertop
PMCID: PMC2023910  PMID: 18333150

Inline graphic Academic Medical Center opened in 1980 and replaced the old pavilion hospitals with separated departments inside Amsterdam. Since that time the concept of a multidisciplinary approach for patients with gastrointestinal disorders, and in particular hepatobiliary and pancreatic diseases, has been developed. This approach started with a strong interest in the non-surgical treatment of HPB diseases by the endoscopic route and stenting developed by Drs Kee S Huibregtse and Guido Tytgat 1,2. The former chairman of the Department of Surgery, Dr Niels van der Heyde, added the expertise of the surgical approach. His main interest was the surgical treatment and effect of radiotherapy for proximal bile duct tumours (Klatskin tumours) 3,4. Drs Huug Obertop (chairman of the Department of Surgery) and Dirk Gouma were appointed in 1993. Together with Dr Thomas van Gulik (head of Experimental Surgery), and Dr Olivier Busch, they lead the ‘surgical’ programme of HPB disorders.

The AMC is a tertiary referral center for HPB diseases in the Netherlands as well as providing a general service for the local community. An important binding factor in the clinical programme as a referral centre is the twice-weekly multidisciplinary HPB meeting. The referral and multidisciplinary management of 250 patients with bile duct injuries after laparoscopic cholecystectomy during the past years emphasises this function 5,6. Gallstone formation and the surgical and non-surgical management of symptomatic gallstone disease have also been studied extensively by the departments of Surgery and Gastroenterology 7,8,9.

During the past decade several aspects of the management of HPB malignancies have been studied, again by cooperation of different departments. The value of diagnostic laparoscopy and other diagnostic modalities such as endosonography, ultrasound and spiral CT-scan, preoperative biliary drainage and perioperative feeding are analysed in different studies 10,11,12,13,14. The role of systemic inflammation and cytokine release in obstructive jaundice and biliary drainage have been analysed in detail 15,16. The non-operative approach of (benign and malignant) HPB diseases is strongly stimulated by the gastroenterologists and the new team of radiologists (Dr Han Lameris, chairman) 2,5,8,17. The results of the pylorus-preserving pancreatoduodenectomy and aspects of centralisation are studied in data from the AMC and the whole of the Netherlands 18. Together with the Department of Pathology (Drs Fiebo ten Kate and Johan Offerhaus) the prognostic role of diagnostic markers in bile duct and pancreatic carcinoma has been investigated 19,20. Effects of chemoradiotherapy in pancreatic carcinoma and radiotherapy in proximal bile duct tumours are studied in collaboration with the Department of Medical Oncology and Radiotherapy (Drs Gonzalez and Van Tienhoven).

Finally within the liver programme, the current studies include the ischaemia-reperfusion phenomenon after liver resection, the effect of extrahepatic cholestasis on liver regeneration, continuous or intermittent vascular inflow occlusion during resection and a new bioartificial liver (BAL) 23,24,25,26. The development of adenoviral gene therapy was initiated recently in a new multidisciplinary research programme. The multidisciplinary approach to patient care has improved the quality of care, as has the combination of clinical and fundamental research by the different members of our HPB team (Figure 1).

Figure 1. .

Figure 1. 

Standing (from left, to right): Dr Erik AJ Rauws (gastroenterologist), Dr Olivier RC Busch (surgeon), Dr Otto M van Delden (radiologist), Dr Daniel C Aronson (pediatric surgeon), Prof G Johan A Offerhaus (pathologist), Prof Thomas M van Gulik (surgeon), Dr Gert Jan van Tienhoven (radiotherapist) Prof Dirk J Gouma (surgeon). Seated (from left to right): Prof Fiebo JW ten Kate (pathologist), Prof Guido NJ Tytgat (gastroenterologist), Prof Huug Obertop (surgeon), Prof Kees Huibregtse (gastroenterologist), Prof Johan S Lameris (radiologist) Missing from this photograph are Dr Rob AFM Chamuleau (hepatologist) and Prof Hugo A Hey (pediatric surgeon).

References

  • 1.Huibregtse K, Tytgat GN. Palliative treatment of obstructive jaundice by transpapillary introduction of large bore bile duct endoprosthesis. Gut. 1982;23:371–5. doi: 10.1136/gut.23.5.371. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Davids PH, Groen AK, Rauws EA, Ttygat GN, Huibregtse K. Randomised trial of self-expanding metal stents versus polyethylene stents for distal malignant biliary obstruction. Lancet. 1992;340:1488–92. doi: 10.1016/0140-6736(92)92752-2. [DOI] [PubMed] [Google Scholar]
  • 3.Van der Heyde MN, Verbeek PC, Lygiadiaklas NJ. Decision-making in the treatment of patients with malignant proximal bile duct obstruction. Sem Liv Dis. 1990;10:145–8. doi: 10.1055/s-2008-1040468. [DOI] [PubMed] [Google Scholar]
  • 4.Gerhards MF, van Gulik TM, de Wit LT, Obertop H, Gouma DJ. Evaluation of morbidity and mortality after resection for hilar cholangiocarcinoma – a single center experience. Surgery. 2000;127:395–404. doi: 10.1067/msy.2000.104250. [DOI] [PubMed] [Google Scholar]
  • 5.Bergman JJ, van den Brink GR, Rauws EA, de Wit L, Obertop H, Huibregtse K, Tytgat GN, Gouma DJ. Treatment of bile duct lesions after laparoscopic cholecystectomy. Gut. 1996;38:141–7. doi: 10.1136/gut.38.1.141. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Boerma D, Rauws EAJ, Keulemans Y, et al. Impaired quality of life 5 years after bile duct injury during laparoscopic cholecystectomy. Ann Surg. 2001;234:750–757. doi: 10.1097/00000658-200112000-00006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Keulemans YC, Mok KS, de Wit LT, Gouma DJ, Groen AK. Hepatic bile versus gallbladder bile: a comparison of protein and concentration and composition in cholesterol gallstone patients. Hepatol. 1998;28:11–6. doi: 10.1002/hep.510280103. [DOI] [PubMed] [Google Scholar]
  • 8.Bergman JJ, Rauws EA, Fockens P, van Berkel AM, Bossuyt PM, Tijssen J, Tytgat GN, Huibregtse K. Randomised trial of endoscopic balloon dilation versus endoscropic sphincterotomy for removal of bile duct stones. Lancet. 1997;349:1124–9. doi: 10.1016/S0140-6736(96)11026-6. [DOI] [PubMed] [Google Scholar]
  • 9.Keulemans Y, Eshuis J, de Haes H, de Wit LT, Gouma DJ. Laparoscopic cholecystectomy: day care versus clinical observation. Ann Surg. 1998;228:724–40. doi: 10.1097/00000658-199812000-00003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Van Dijkum EJ, Sturm PD, de Wit LT, Offerhaus J, Obertop H, Gouma DJ. Cytology of peritoneal lavage performed during staging laparoscopic gastrointestinal malignancies: is it useful? Ann Surg. 1998;228:728–33. doi: 10.1097/00000658-199812000-00002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Phoa SS, Reeders JW, Stoker J, Rauws EA, Gouma DJ, Lameris JS. CT criteria for venous invasion in patients with pancreatic head carcinoma. Br J Radiol ;:l. 2000;73:159–64. doi: 10.1259/bjr.73.875.11144792. [DOI] [PubMed] [Google Scholar]
  • 12.Van Driel BE, Van Gulik TM, Sturm PD, et al. Differential diagnosis of chronic pancreatitis and pancreatic carcinoma in brush cytology specimens. Cancer Res. 1999;59:5732–6. [PubMed] [Google Scholar]
  • 13.Sewnath ME, Birjmohun RS, Rauws EA, Huibregtse K, Obertop H, Gouma DJ. The effect of preoperative biliary drainage on postoperative complications after pancreaticoduodenectomy. J Am Coll Surg. 2001;192:726–34. doi: 10.1016/s1072-7515(01)00819-5. [DOI] [PubMed] [Google Scholar]
  • 14.VanBerge Henegouwen MI, Akkermans LM, van Gulik TM, et al.Prospective, randomized trial on the effect of cyclic versus continuous enteral nutrition on postoperative gastric function after pylorus preserving pancreatoduodenectomy Ann Surg 1997;226:677–85;discussion 685–7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Kimmings AN, van Deventer SJ, Obertop H, Rauws EA, Huibregtse K, Gouma DJ. Endotoxin, cytokines and endotoxin binding proteins in obstructive jaundice and after preoperative biliary drainage. Gut. 2000;46:725–31. doi: 10.1136/gut.46.5.725. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Sewnath ME, Levels HH, Oude Elferink R, et al. Endotoxin-induced mortality in bile ductligated rats after administration of reconstituted high-density lipoprotein. Hepatol. 2000;32:1289–99. doi: 10.1053/jhep.2000.20525. [DOI] [PubMed] [Google Scholar]
  • 17.Vos PM, van Beek EJ, Smits NJ, Rauws EA, Gouma DJ, Reeders JW. Percutaneous balloon dilatation for benign hepaticojejunostomy strictures. Abdom Imaging. 2000;25:134–8. doi: 10.1007/s002619910032. [DOI] [PubMed] [Google Scholar]
  • 18.Gouma DJ, van Geenen RC, van Gulik TM, et al. Rates of complications and death after pancreaticduodenectomy: risk factors and the impact of hospital volume. Ann Surg. 2000;32:786–95. doi: 10.1097/00000658-200012000-00007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Rijken AM, Umezawa A, van Gulik TM, et al. Prognostic value of cell proliferation (Ki-67 antigen) and nuclear DNA content in clinically resectable, distal bile duct carcinoma. Ann Surg Oncol. 1998;5:699–705. doi: 10.1007/BF02303480. [DOI] [PubMed] [Google Scholar]
  • 20.Sturm PD, Hruban RH, Ramsoekh TB, et al. The potential diagnostic use of K-ras condon 12 and p53 alteration brush cytology from the pancreatic head region. J Pathol. 1998;186:247–53. doi: 10.1002/(SICI)1096-9896(1998110)186:3<247::AID-PATH179>3.0.CO;2-J. [DOI] [PubMed] [Google Scholar]
  • 21.Ceha HM, van Tienhoven G, Gouma DJ, et al. Feasibility and efficacy of high dose confirmal radiotherapy for patients with locally advanced pancreatic carcinoma. Cancer. 2000;89:2222–9. doi: 10.1002/1097-0142(20001201)89:11<2222::aid-cncr10>3.0.co;2-v. [DOI] [PubMed] [Google Scholar]
  • 22.Gerhards MF, Gonzalez DG, ten Hoopen-Neumann H, van Gulik TM, de Wit LT, Gouma DJ. Prevention of implantation metastases after resection of proximal bile duct tumours with preoperative low dose radiation therapy. Eur J Surg Oncol. 2000;26:480–5. doi: 10.1053/ejso.1999.0926. [DOI] [PubMed] [Google Scholar]
  • 23.Straatsburg IH, Boernmeester MA, Wolbink GJ, et al. Complement activation induced by ischaemia-reperfusion in humans: a study in patients undergoing partial hepatectomy. Hepato. 2000;32:783–91. doi: 10.1016/s0168-8278(00)80247-0. [DOI] [PubMed] [Google Scholar]
  • 24.Van Wagensveld BA, van Gulik TM, Gelderblom HC, et al. Prolonged continuous or intermittent vascular inflow occlusion during hemihepatectomy in pigs. Ann Surg. 1999;229:376–84. doi: 10.1097/00000658-199903000-00011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Aronson DC, Chamuleau RA, Fredericks WM, Bosman DK, Oosting J. The effect of extrahepatic cholestasis on liver regeneration after hepatectomy in the rat. Liver. 1995;15:242–6. doi: 10.1111/j.1600-0676.1995.tb00679.x. [DOI] [PubMed] [Google Scholar]
  • 26.Flendrig LM, Chamuleau RA, Maas MA, et al. Evaluation of a novel bioartificial liver in rats with complete liver ischemia: treatment efficacy and species-specific alpha-GST detection to monitor hepatocyte viability. J Hepatol. 1999;30:311–20. doi: 10.1016/s0168-8278(99)80078-6. [DOI] [PubMed] [Google Scholar]

Articles from HPB : The Official Journal of the International Hepato Pancreato Biliary Association are provided here courtesy of Elsevier

RESOURCES